Literature DB >> 19169896

Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women.

Xiao-Rong Wang1, Ignatius T S Yu, Yuk Lan Chiu, Hong Qiu, Zhenming Fu, William Goggins, Joseph S K Au, Lap-Ah Tse, Tze-Wai Wong.   

Abstract

Chinese women in Hong Kong have among the highest incidence and mortality of lung cancer in the world, in spite of a low prevalence of smoking. We carried out this population-based case-control study to evaluate the associations of previous lung disease and family cancer history with the occurrence of lung cancer among them. We selected 212 cases that were newly diagnosed with primary lung cancer, and randomly sampled 292 controls from the community, frequency matched by age group. All the cases and controls were lifetime nonsmokers. We estimated the main effects of preexisting asthma, pulmonary tuberculosis, pneumonia, chronic bronchitis, and family lung/all cancer history, using unconditional logistic regression, accounting for various potential risk factors and confounders. All of the previous lung diseases, except chronic bronchitis, were related to an elevated risk for lung cancer, and the association with asthma was significant. Those who had more than one previous lung disease tended to be at higher risk than those with only one of them. Positive family history of any cancer was associated with over 2-fold risk than negative family history. The joint effect of positive history of previous pulmonary diseases and positive family cancer history appeared to be additive, indicating the two factors acted independently. The results support an etiological link of preexisting lung disease and family cancer history to the risk of lung cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19169896     DOI: 10.1007/s10552-008-9289-4

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  18 in total

Review 1.  Case-control studies in pharmacoeconomic research: an overview.

Authors:  J Jaime Caro; Krista F Huybrechts
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.

Authors:  William J McCarthy; Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

3.  Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei
Journal:  Curr Cancer Ther Rev       Date:  2012-05-01

4.  Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Michele L Coté; Mei Liu; Stefano Bonassi; Monica Neri; Ann G Schwartz; David C Christiani; Margaret R Spitz; Joshua E Muscat; Gad Rennert; Katja K Aben; Angeline S Andrew; Vladimir Bencko; Heike Bickeböller; Paolo Boffetta; Paul Brennan; Hermann Brenner; Eric J Duell; Eleonora Fabianova; John K Field; Lenka Foretova; Søren Friis; Curtis C Harris; Ivana Holcatova; Yun-Chul Hong; Dolores Isla; Vladimir Janout; Lambertus A Kiemeney; Chikako Kiyohara; Qing Lan; Philip Lazarus; Jolanta Lissowska; Loic Le Marchand; Dana Mates; Keitaro Matsuo; Jose I Mayordomo; John R McLaughlin; Hal Morgenstern; Heiko Müeller; Irene Orlow; Bernard J Park; Mila Pinchev; Olaide Y Raji; Hedy S Rennert; Peter Rudnai; Adeline Seow; Isabelle Stucker; Neonila Szeszenia-Dabrowska; M Dawn Teare; Anne Tjønnelan; Donatella Ugolini; Henricus F M van der Heijden; Erich Wichmann; John K Wiencke; Penella J Woll; Ping Yang; David Zaridze; Zuo-Feng Zhang; Carol J Etzel; Rayjean J Hung
Journal:  Eur J Cancer       Date:  2012-03-19       Impact factor: 9.162

5.  The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta-analysis.

Authors:  Amanda B Muir; Kelly A Whelan; Michael K Dougherty; Bailey Aaron; Brianna Navarre; Seema S Aceves; Evan S Dellon; Elizabeth T Jensen
Journal:  Clin Exp Allergy       Date:  2019-12-20       Impact factor: 5.018

6.  Circulating markers of interstitial lung disease and subsequent risk of lung cancer.

Authors:  Meredith S Shiels; Anil K Chaturvedi; Hormuzd A Katki; Bernadette R Gochuico; Neil E Caporaso; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-09       Impact factor: 4.254

7.  Lower risk of lung cancer after multiple pneumonia diagnoses.

Authors:  Jill Koshiol; Melissa Rotunno; Dario Consonni; Angela Cecilia Pesatori; Sara De Matteis; Alisa M Goldstein; Anil K Chaturvedi; Sholom Wacholder; Maria Teresa Landi; Jay H Lubin; Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

8.  Increased lung cancer risk among patients with pneumococcal pneumonia: a nationwide population-based cohort study.

Authors:  Te-Yu Lin; Wen-Yen Huang; Jung-Chung Lin; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao; Jun-Jun Yeh
Journal:  Lung       Date:  2013-10-23       Impact factor: 2.584

Review 9.  Asthma and risk of lung cancer.

Authors:  M T García Sanz; F J González Barcala; J M Alvarez Dobaño; L Valdés Cuadrado
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

10.  Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race.

Authors:  Lisa D Gardner; Christopher A Loffredo PhD; Patricia Langenberg; Diane Marie St George; Janaki Deepak; Curtis C Harris; Sania Amr
Journal:  Ann Epidemiol       Date:  2018-05-07       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.